Dr. Jorg Taubel will be attending the EPI | Lifestyle Scientific Sessions 2024. Taking place from 18th to 21st March in Chicago, Illinois, this event is a cornerstone for professionals in the field of epidemiology, prevention, and lifestyle medicine, with a particular focus on cardiometabolic health.
Dr. Taubel's presence at the conference promises to enrich the discussions and debates surrounding epidemiological cardiovascular issues and the impact of lifestyle trends. We anticipate engaging sessions that delve deep into understanding and addressing the intersection of lifestyle factors and cardiovascular health.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
